UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow's Milk Protein Allergy: A Randomized, Multi-Center Trial

Nutrients, 2022-01, Vol.14 (3), p.530

2022

Volltextzugriff (PDF)

Synthesis and olefin homo- and copolymerization behavior of new vanadium complexes bearing [OSSO]-type ligands

Reaction kinetics, mechanisms and catalysis, 2017-10, Vol.122 (1), p.259-273

2017

Volltextzugriff (PDF)

Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial

JAMA neurology, 2021-03, Vol.78 (3), p.285

2021

Volltextzugriff (PDF)

Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial

Epilepsia (Copenhagen), 2019-02, Vol.60 (2), p.294-302

2019

Volltextzugriff (PDF)

A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox–Gastaut syndrome (ELEKTRA)

Epilepsia (Copenhagen), 2022-10, Vol.63 (10), p.2671-2683

2022

Volltextzugriff (PDF)

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

The New England journal of medicine, 2017-05, Vol.376 (21), p.2011-2020

2017

Volltextzugriff (PDF)

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

The Lancet (British edition), 2018-03, Vol.391 (10125), p.1085-1096

2018

Volltextzugriff (PDF)

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants

The New England journal of medicine, 2020-07, Vol.383 (5), p.415-425

2020

Volltextzugriff (PDF)

Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial

Lancet neurology, 2022-05, Vol.21 (5), p.417-427

2022

Volltextzugriff (PDF)

Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial

Epilepsia (Copenhagen), 2021-10, Vol.62 (10), p.2505-2517

2021

Volltextzugriff (PDF)

Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials

Epilepsia (Copenhagen), 2021-09, Vol.62 (9), p.2218-2227

2021

Volltextzugriff (PDF)

Infant Formula With a Specific Blend of Five Human Milk Oligosaccharides Drives the Gut Microbiota Development and Improves Gut Maturation Markers: A Randomized Controlled Trial

Frontiers in nutrition (Lausanne), 2022-07, Vol.9, p.920362-920362

2022

Volltextzugriff (PDF)

Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland

Therapeutic advances in chronic disease, 2022, Vol.13, p.204062232211179-20406223221117982

2022

Volltextzugriff (PDF)

Synthesis and anti-yeast evaluation of novel 2-alkylthio-4-chloro-5-methyl-N-[imino-(1-oxo-(1H)-phthalazin-2-yl)methyl]benzenesulfonamide derivatives

Molecules (Basel, Switzerland), 2014-09, Vol.19 (9), p.13704-13723

2014

Volltextzugriff (PDF)

Analysis of Nurses' Attitudes toward Patient Death

International journal of environmental research and public health, 2022-10, Vol.19 (20), p.13119

2022

Volltextzugriff (PDF)

The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis

Respiratory research, 2020-01, Vol.21 (1), p.11-11, Article 11

2020

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Humans
(10)
Double-Blind Method
(7)
Patients
(7)
Treatment Outcome
(7)
Child
(6)
Clinical Neurology
(6)
Clinical Trials
(6)
Convulsions & Seizures
(6)
Neurosciences & Neurology
(6)
Seizures
(6)
Child, Preschool
(5)
Double-Blind Studies
(5)
Epilepsies, Myoclonic - Drug Therapy
(5)
Female
(5)
Seizures - Drug Therapy
(5)
Adolescent
(4)
Anticonvulsants - Adverse Effects
(4)
Cannabinoids
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow's Milk Protein Allergy: A Randomized, Multi-Center Trial

Synthesis and olefin homo- and copolymerization behavior of new vanadium complexes bearing [OSSO]-type ligands

Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial

Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial

A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox–Gastaut syndrome (ELEKTRA)

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants

Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial

Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial

Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials

Infant Formula With a Specific Blend of Five Human Milk Oligosaccharides Drives the Gut Microbiota Development and Improves Gut Maturation Markers: A Randomized Controlled Trial

Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland

Synthesis and anti-yeast evaluation of novel 2-alkylthio-4-chloro-5-methyl-N-[imino-(1-oxo-(1H)-phthalazin-2-yl)methyl]benzenesulfonamide derivatives

Analysis of Nurses' Attitudes toward Patient Death

The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis

Suchergebnisse filtern